Selected high impact publications from EMRO countries

(Impact factors are shown for each paper in brackets)

Iran:

 Nanoemulsion of atovaquone as a promising approach for treatment of acute and chronic toxoplasmosis.(3.773)

 Purification of extra cellular poly-γ-glutamic acid as an antibacterial agent using anion exchange chromatography.(3.671)

 Effects of vitamin D deficiency on incidence risk of gestational diabetes mellitus: A systematic review and meta-analysis.(3.675)

 Evidence and prospective of plant derived flavonoids as antiplatelet agents: Strong candidates to be drugs of future.(3.8)

 Gender differences in epidemiology, pathophysiology, and treatment of hypertension.(3.417)

 Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms.(11.127)

Egypt:

 Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis.(2.787)

 Extracellular cholesterol oxidase production by Streptomyces aegyptia, in vitro anticancer activities against rhabdomyosarcoma, breast cancer cell-lines and in vivo apoptosis.(4.259)

 Flavonoid fraction of Cajanus cajan prohibited the mutagenic properties of cyclophosphamide in mice in vivo.(3.680)

 Part III: Novel checkpoint kinase 2 (Chk2) inhibitors; design, synthesis and biological evaluation of pyrimidine-benzimidazole conjugates.(4.519)

Morocco:

 Seaweed bioactive compounds against pathogens and microalgae: potential uses on pharmacology and harmful algae bloom control.(3.503)

Lebanon:

 Reduced integration and improved segregation of functional brain networks in alzheimers disease.(3.465)

 Proteome profiling in the aorta and kidney of type 1 diabetic rats.(2.806)

 Hydrogel tethering enhances interdomain stabilization of single-chain antibodies.(4.818)